Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.
about
Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Fostamatinib for the Treatment ...... ed, Placebo-Controlled Trials.
@en
Fostamatinib for the Treatment ...... ed, Placebo-Controlled Trials.
@nl
type
label
Fostamatinib for the Treatment ...... ed, Placebo-Controlled Trials.
@en
Fostamatinib for the Treatment ...... ed, Placebo-Controlled Trials.
@nl
prefLabel
Fostamatinib for the Treatment ...... ed, Placebo-Controlled Trials.
@en
Fostamatinib for the Treatment ...... ed, Placebo-Controlled Trials.
@nl
P2093
P2860
P50
P356
P1476
Fostamatinib for the treatment ...... zed, placebo-controlled trials
@en
P2093
Andrzej Hellmann
Anne-Marie Duliege
Donald M Arnold
Elliot Grossbard
Hany Zayed
Jacek Treliński
Jerzy Windyga
Jiří Mayer
Liliya Sivcheva
Nichola Cooper
P2860
P304
P356
10.1002/AJH.25125
P577
2018-05-15T00:00:00Z